Aveo Capital Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-8,286
| Closed | -$272K | – | 364 |
|
|
2023
Q4 | $272K | Sell |
8,286
-7,750
| -48% | -$254K | 0.03% | 283 |
|
|
2023
Q3 | $447K | Hold |
16,036
| – | – | 0.06% | 211 |
|
|
2023
Q2 | $547K | Hold |
16,036
| – | – | 0.07% | 192 |
|
|
2023
Q1 | $482K | Sell |
16,036
-100
| -0.6% | -$3.01K | 0.06% | 198 |
|
|
2022
Q4 | $456K | Buy |
16,136
+141
| +0.9% | +$3.98K | 0.07% | 200 |
|
|
2022
Q3 | $526K | Hold |
15,995
| – | – | 0.09% | 160 |
|
|
2022
Q2 | $504K | Hold |
15,995
| – | – | 0.08% | 176 |
|
|
2022
Q1 | $735K | Buy |
15,995
+11,658
| +269% | +$536K | 0.13% | 134 |
|
|
2021
Q4 | $266K | Sell |
4,337
-17
| -0.4% | -$1.04K | 0.05% | 239 |
|
|
2021
Q3 | $325K | Buy |
+4,354
| New | +$325K | 0.07% | 200 |
|